Pharmacokinetics of indoramin in man.
Open Access
- 1 June 1976
- journal article
- clinical trial
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 3 (3) , 489-495
- https://doi.org/10.1111/j.1365-2125.1976.tb00626.x
Abstract
1 The fate of oral and intravenous indoramin has been studied after single doses in man using the 14C labelled drug. Plasma concentrations of indoramin have been determined during chronic oral antihypertensive therapy employing a stable isotope dilution assay. 2 Following singleoral dosing the drug is well absorbed and extensively metabolised. Faecal excretion in 72 h accounts for 46% of the administered radioactivity of which approximately 4% is associated with indoramin. Less than 2% of the radioactivity in urine is accountable as the concentration of total metabolites. Peak plasma levels both of drug and metabolites occur 1‐2 h after dosing, the maximal lowering of blood pressure occurring at this time. 3 The clearance of indoramin, determined after intravenous administration is of the same order as liver blood flow. In the isolated perfused rat liver, the extraction ratio is 0.98.Keywords
This publication has 9 references indexed in Scilit:
- “First-pass” metabolism of paracetamol in rat liverJournal of Pharmacy and Pharmacology, 1974
- Clinical evaluation of indoramin, a new antihypertensive agentEuropean Journal of Clinical Pharmacology, 1973
- The dependence of paracetamol absorption on the rate of gastric emptyingBritish Journal of Pharmacology, 1973
- Pharmacologic studies of indoramin in manClinical Pharmacology & Therapeutics, 1972
- Treatment of Essential Hypertension with Combined Vasodilation and Beta-Adrenergic BlockadeNew England Journal of Medicine, 1972
- Cardiovascular actions of Wy 21901, a new hypotensive and anti-arrhythmic agent.1970
- Plasma propranolol levels in adults With observations in four childrenClinical Pharmacology & Therapeutics, 1970
- Gluconeogenesis in the perfused rat liverBiochemical Journal, 1966